(Q47258530)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

review article

1 reference

title

Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference

1 reference

inflammatory bowel diseases

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

author name string

Mirko Di Ruscio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Filippo Vernia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Giuseppe Frieri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

Giovanni Latella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

publication date

1 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

8 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

page(s)

78-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis

8 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

A soluble protein characteristic of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Calcium-dependent and -independent interactions of the S100 protein family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Laboratory markers in IBD: useful, magic, or unnecessary toys?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Proinflammatory S100A12 can activate human monocytes via Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal S100A12 in healthy infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Role of the acidic tail of high mobility group protein B1 (HMGB1) in protein stability and DNA bending

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

High mobility group protein B1 enhances DNA repair and chromatin modification after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Natural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein: a dangerous trio in HIV-1 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Role of HMGB1 in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Masquerader: high mobility group box-1 and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

HMGB1, a novel inflammatory cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

High-mobility group box 1 represents a potential marker of disease activity and novel therapeutic target in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

The role of HMGB1 in the pathogenesis of rheumatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal elastase reflects disease activity in active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Evaluation of mucosal healing of ulcerative colitis by a quantitative fecal immunochemical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin Vs. Fecal Immunochemical Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Prediction of flare-ups of ulcerative colitis using quantitative immunochemical fecal occult blood test

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Ulcerative colitis patients in clinical remission demonstrate correlations between fecal immunochemical test results, mucosal healing, and risk of relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Alpha 1-antitrypsin, a reliable endogenous marker for intestinal protein loss and its application in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestiv

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Defensins. Natural peptide antibiotics of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Human lysozyme: sequencing of a cDNA, and expression and secretion by Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal lysozyme: determination, reference intervals and some data in gastro-intestinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal pyruvate kinase (M2-PK): a new predictor for inflammation and severity of pouchitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Myeloperoxidase: friend and foe

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Dysregulation of human beta-defensin-2 protein in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Dynamics of the human gut microbiome in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fungal microbiota dysbiosis in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Biomarkers of Inflammation in Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Genetics of Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Fecal HMGB1 Is a Novel Marker of Intestinal Mucosal Inflammation in Pediatric Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

The Impact of Matrix Metalloproteinases and Their Tissue Inhibitors in Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FIBD%2FIZX011

Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1)

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.2119/MOLMED.2011.00389

Identifiers

DOI

10.1093/IBD/IZX011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29272479%20AND%20SRC:MED&resulttype=core&format=json

8 April 2020

1 reference